Jaka Biotech Co (BJSE:920165) Total Receivables: ¥50.3 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920165 Jaka Biotech Co Ltd BJSE:920165
20 GF Score
Price ¥36.82
! 2 Warning Signs
View Full Analysis

What is Jaka Biotech Co Total Receivables?

Jaka Biotech Co BJSE:920165 20 Total Receivables is ¥50.3 Mil as of Jun. 2026. GuruFocus rates BJSE:920165 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

Jaka Biotech Co's Total Receivables for the quarter that ended in Jun. 2026 was ¥50.3 Mil.

Jaka Biotech Co Total Receivables Related Terms

Jaka Biotech Co Total Receivables Historical Data

* Premium members only.

The historical data trend for Jaka Biotech Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jaka Biotech Co Total Receivables Chart

Jaka Biotech Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Receivables
34.32 40.49 49.31 48.52

Jaka Biotech Co Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.48 57.68 48.52 0.00 50.31
BJSE:920165
20GF Score
Jaka Biotech Co Ltd BJSE:920165
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jaka Biotech Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ¥50.3 Mil mean?
Jaka Biotech Co (BJSE:920165) has a Total Receivables of ¥50.3 Mil as of Jun. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Jaka Biotech Co and its competitors.
Is Jaka Biotech Co's Total Receivables too high?
Jaka Biotech Co's current Total Receivables is ¥50.3 Mil. Overall, Jaka Biotech Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Jaka Biotech Co's Total Receivables compare to PG and CL?
Jaka Biotech Co's Total Receivables of ¥50.3 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Consumer Packaged Goods company?
A good Total Receivables depends on the Consumer Packaged Goods industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Jaka Biotech Co and its competitors. Jaka Biotech Co's current Total Receivables is ¥50.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jaka Biotech Co stock overvalued right now?
Jaka Biotech Co (BJSE:920165) has a current Total Receivables of ¥50.3 Mil. The current Total Receivables is ¥50.3 Mil. Jaka Biotech Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Jaka Biotech Co (BJSE:920165), the current Total Receivables is ¥50.3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jaka Biotech Co Business Description

Address No. 818, Tiangong Road, Jinshan District, Shanghai, CHN, 201507
Jaka Biotech Co Ltd is engaged in the research, development, production and sales of cosmetic functional ingredients. Its operations include pharmaceutical manufacturing, testing and inspection services, manufacturing and sales of specialty chemical products, and bio-based materials.
20GF Score

Get the complete analysis for BJSE:920165

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥36.82
Price